Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders

Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders

The goal of this clinical trial is to evaluate the efficacy and safety of transcranial direct current stimulation (tDCS) in reducing core symptoms of different psychiatric disorders using validated clinical scales.

• To assess response and remission rates.
• To evaluate the durability of treatment effects over follow-up.
• To examine effects on cognition, daily functioning, and quality of life.
• To monitor tolerability and adverse events.

Inclusion Criteria:

• Age between 16 and 65 years
• Fulfillment of DSM-5 diagnostic criteria for one of the target disorders
• Stable pharmacological treatment for at least four weeks prior to enrollment (if applicable)
• Ability to provide informed consent

Exclusion Criteria:

• History of epilepsy or seizures
• Presence of intracranial metallic implants or implanted electronic devices
• Severe neurological disorders (e.g., brain tumors)
• Pregnancy
• Active substance use disorder
• Severe cognitive impairment or comorbid psychiatric disorders interfering with assessment